Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: Is there a relationship between urothelial and prostate cancer?

BJU International

Volumn 103, Issue 8, 2009, Pages 1058-1063

  Barbisan, Francesca ^a   Mazzucchelli, Roberta ^a   Scarpelli, Marina ^a   Lopez Beltran, Antonio ^b   Cheng, Liang ^c   Kirkali, Ziya ^d   Montironi, Rodolfo ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Bladder; Cystoprostatectomy; Incidental; Prostate cancer; Urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CANCER INVASION; CARCINOMA IN SITU; CLINICAL FEATURE; CONTROLLED STUDY; CYSTECTOMY; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; STROMA CELL; URETHRA CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA IN SITU; CYSTECTOMY; HUMANS; INCIDENTAL FINDINGS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROSTATECTOMY; PROSTATIC NEOPLASMS; URINARY BLADDER NEOPLASMS;

EID: 63449114509     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08207.x     Document Type: Article

References (41)

1. Kessler TM, Burkhard FC, Perimenis P et al. Attempted nerve sparing surgery and age have a significant effect on urinary continence and erectile function after radical cystoprostatectomy and ileal orthotopic bladder substitution. J Urol 2004 172 : 1323 7
2. Schoenberg MP, Walsh PC, Breazeale DR, Marshall FF, Mostwin JL, Brendler CB. Local recurrence and survival following nerve sparing radical cystoprostatectomy for bladder cancer: 10-year followup. J Urol 1996 155 : 490 4
3. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes retrieved on outcome in patients with muscle invasive bladder cancer. J Urol 2002 167 : 1295 8
4. Stein JP, Lieskovsky G, Cote R et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol 2001 19 : 666 75
5. Revelo MP, Cookson MS, Chang SS, Shook MF, Smith JA Shappell SB. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implications for possible apical sparing surgery. J Urol 2004 171 : 646 51
6. Ruffion A, Manel A, Massoud W et al. Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology 2005 65 : 703 7
7. Esrig D, Freeman JA, Elmajian DA et al. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion. J Urol 1996 156 : 1071 6
8. Pettus JA, Al-Ahmadie H, Barocas DA et al. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur Urol 2008 53 : 370 5
9. Schellhammer PF, Bean MA, Whitmore WF Jr. Prostatic involvement by transitional cell carcinoma: pathogenesis, patterns and prognosis. J Urol 1977 118 : 399 403
10. Wood DP Montie JE, Pontes JE, VanderBrug Medendorp S, Levin HS. Transitional cell carcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. J Urol 1989 141 : 346 9
11. Scardino PT, Weaver R, Hudson MA. Early detection of prostate cancer. Hum Pathol 1992 23 : 211 22
12. Mazzucchelli R, Barbisan F, Scarpelli M et al. Is incidental prostate cancer in patients undergoing radical cystoprostatectomy clinically significant? AJCP 2008 (in press)
13. Montironi R, Mazzucchelli R, Santinelli A, Scarpelli M, Lopez-Beltran A, Bostwick DG. Incidentally detected prostate cancer in cystoprostatectomies: pathological and morphometric comparison with clinically detected cancer in totally embedded specimens. Hum Pathol 2005 36 : 646 54
14. Sobin LH, Wittekind Ch. Urologic tumours: prostate. In Sobin LH, Wittekind Ch, TNM Classification of Malignant Tumours, 6th edn. New York : Wiley-Liss, 2002 : 184 7
15. Epstein JI, Allsbrook WC Amin MB, Egevad LL ISUP, Grading Committee. The International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol 2005 29 : 1228 42
16. Helpap B, Egevad L. Correlation of modified Gleason grading with pT stage of prostatic carcinoma after radical prostatectomy. Anal Quant Cytol Histol 2008 30 : 1 7
17. Helpap B, Egevad L. Correlation of modified Gleason grading of prostate carcinoma with age, serum prostate specific antigen and tumor extent in needle biopsy specimens. Anal Quant Cytol Histol 2008 30 : 133 8
18. Hofstädter F, Amin MB, Delahunt B et al. Tumours of the urethra. In Eble JN, Sauter G, Epstein JI, Sesterhenn IA, WHO Classification of Tumours. Pathology and Genetics. Tumours of the Urinary System and Male Genital Organs. Lyon : IARC Press, 2004 : 154 7
19. Donat SM, Genega EM, Herr HW, Reuter VE. Mechanisms of prostatic stromal invasion in patients with bladder cancer: clinical significance. J Urol 2001 165 : 1117 20
20. Scattoni V, Montironi R, Mazzucchelli R et al. Pathological changes of high-grade prostatic intraepithelial neoplasia and prostate cancer after monotherapy with bicalutamide 150 mg. BJU Int 2006 98 : 54 8
21. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 1994 271 : 368 74
22. Canda AE, Tuzel E, Mungan MU, Yorukoglu K, Kirkali Z. Conservative management of mucosal prostatic urethral involvement in patients with superficial transitional cell carcinoma of the bladder. Eur Urol 2004 45 : 465 9
23. Kirkali Z, Canda AE. Superficial urothelial cancer in the prostatic urethra. Sci World J 2006 6 : 2603 10
24. Wolfe JH, Lloyd-Davies RW. The management of transitional cell carcinoma in the prostate. Br J Urol 1981 53 : 253 7
25. Shen SS, Lerner SP, Muezzinoglu B, Truong LD, Amiel G, Wheeler TM. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance. Hum Pathol 2006 37 : 726 34
26. Autorino R, Di Lorenzo G, Damiano R et al. Pathology of the prostate in radical cystectomy specimens: a critical review. Surg Oncol 2008 Epub ahead of print
27. Cindolo L, Benincasa G, Autorino R et al. Prevalence of silent prostatic adenocarcinoma in 165 patients undergone cystoprostatectomy: a retrospective study. Oncol Rep 2001 8 : 269 71
28. Conrad S, Hautmann SH, Henke RP et al. Detection and characterization of early prostate cancer by six systematic biopsies and fine needle aspiration cytology in prostates from bladder cancer patients. Eur Urol 2001 39 : 25 9
29. Montie JE, Wood DP Pontes JE, Boyett JM, Levin HS. Adenocarcinoma of the prostate in cystoprostatectomy specimens removed for bladder cancer. Cancer 1989 63 : 381 5
30. Abbas F, Hochberg D, Civantos F, Soloway M. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Eur Urol 1996 30 : 322 6
31. Moutzouris G, Barbatis C, Plastiras D et al. Incidence and histological findings of unsuspected prostatic adenocarcinoma in radical cystoprostatectomy for transitional cell carcinoma of the bladder. Scand J Urol Nephrol 1999 33 : 27 30
32. Lee SH, Chang PL, Chen SM et al. Synchronous primary carcinomas of the bladder and prostate. Asian J Androl 2006 8 : 357 9
33. Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000 85 : 60 7
34. Chun TY. Coincidence of bladder and prostate cancer. J Urol 1997 157 : 65 7
35. Kurokawa K, Ito K, Yamamoto T et al. Comparative study on the prevalence of clinically detectable prostate cancer in patients with and without bladder cancer. Urology 2004 63 : 268 72
36. Liskow AS, Neugut AI, Benson M, Olsson CA, Birkhoff J, Chang CH. Multiple primary neoplasms in association with prostate cancer in black and white patients. Cancer 1987 59 : 380 4
37. Sheldon CA, Williams RD, Fraley EE. Incidental carcinoma of the prostate: a review of the literature and critical reappraisal of classification. J Urol 1980 124 : 626 31
38. Singh A, Kinoshita Y, Rovito PM et al. Higher than expected association of clinical prostate and bladder cancers. J Urol 2005 173 : 1526 9
39. Winkler MH, Livni N, Mannion EM, Hrouda D, Christmas T. Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens. BJU Int 2007 99 : 554 8
40. Singh A, Jones RF, Friedman H et al. Expression of p53 and pRb in bladder and prostate cancers of patients having both cancers. Anticancer Res 1999 19 : 5415 7
41. Amara N, Palapattu GS, Schrage M et al. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Cancer Res 2001 61 : 4660 5